Gabapentinoids freely pass the blood–brain barrier and are commonly used for therapy of seizures and neuropathic pain, though the websites of central motion are poorly understood. In one 10-week RCT183, gabapentin significantly improved subjective cough measures and objective cough frequency in patients with persistent refractory cough; nevertheless, clinical advantages were not sustained after therapy...